Inventor · disambiguated record
Michel Streuli
Also filed as: STREULI MICHEL
14 granted patents·2 pending applications·83 citations·filing 1990–2022
91Inventor score
Files withDANA FARBER CANCER INST INC6PIONYR IMMUNOTHERAPEUTICS INC4PORTSMOUTH MERGER SUB II LLC2SANOFI SA2BLANC VERONIQUE1
Top patents by PatentIndex Score
16 records- 0194US10508148B2Anti-TREM2 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2019·Granted Dec 17, 2019·11 cites·71 claims
- 0289US12428481B2Anti-TREM2 antibodies and related methodsPORTSMOUTH MERGER SUB II LLC·Filed 2022·Granted Sep 30, 2025·1 cites·20 claims
- 0382US11505602B2Anti-TREM2 antibodies and related methodsPIONYR IMMUNOTHERAPEUTICS INC·Filed 2019·Granted Nov 22, 2022·1 cites·26 claims
- 0482US8460667B2EPHA2 receptor antagonist antibodiesBLANC VERONIQUE·Filed 2007·Granted Jun 11, 2013·8 cites·65 claims
- 0577USRE47123EEPHA2 receptor antagonist antibodiesSANOFI SA·Filed 2007·Granted Nov 13, 2018·2 cites·72 claims
- 0676US6180849B1Trangenic mice with a disruption in the tiar geneDANA FARBER CANCER INST INC·Filed 1998·Granted Jan 30, 2001·28 cites·22 claims
- 0771US8992912B2Methods of use for antibodies that specifically bind to the EphA2 receptorSANOFI SA·Filed 2013·Granted Mar 31, 2015·1 cites·29 claims
- 0866US12378311B2Anti-MARCO antibodies and uses thereofPORTSMOUTH MERGER SUB II LLC·Filed 2022·Granted Aug 5, 2025·0 cites·31 claims
- 0964US11572407B2Anti-MARCO antibodies and uses thereofPIONYR IMMUNOTHERAPEUTICS INC·Filed 2021·Granted Feb 7, 2023·0 cites·58 claims
- 1053US5298407ADNA encoding a protein active in lymphocyte-mediated cytotoxicityDANA FARBER CANCER INST INC·Filed 1991·Granted Mar 29, 1994·9 cites·15 claims
- 1151US5340935ADNAS encoding proteins active in lymphocyte-medicated cytotoxicityDANA FARBER CANCER INST INC·Filed 1992·Granted Aug 23, 1994·8 cites·7 claims
- 1248US2015274824A1Antagonist antibody for the treatment of cancerSANOIFI·Filed 2015·Application pending·0 cites
- 1347US2021317211A1Methods of using anti-trem2 antibodiesPIONYR IMMUNOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1444US5079343AIntracellular antigen found in subpopulation of cd8+ t lymphocytes and monoclonal antibody reactive with sameDANA FARBER CANCER INST INC·Filed 1990·Granted Jan 7, 1992·5 cites·2 claims
- 1539US5994070ATrio molecules and uses related theretoDANA FARBER CANCER INST INC·Filed 1997·Granted Nov 30, 1999·9 cites·25 claims
- 1631US5837811AProteins active in lymphocyte-mediated cytotoxicityDANA FARBER CANCER INST INC·Filed 1994·Granted Nov 17, 1998·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Michel Streuli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →